Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon

被引:10
作者
Overbury, Rebecca [1 ,2 ]
Murtaugh, Maureen A. [3 ]
Fischer, Aryeh [4 ]
Frech, Tracy M. [5 ]
机构
[1] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pediat, Salt Lake City, UT USA
[3] Univ Utah, Salt Lake Vet Affair Med Ctr, Dept Internal Med, Div Epidemiol, Salt Lake City, UT USA
[4] Univ Colorado, Sch Med, Div Rheumatol, Denver, CO 80202 USA
[5] Univ Utah, Salt Lake Vet Affair Med Ctr, Dept Internal Med, Div Rheumatol, Salt Lake City, UT 84112 USA
基金
美国国家卫生研究院;
关键词
Diagnostic tests; Methodology; Raynaud's syndrome; Rheumatic diseases; Scleroderma; Systemic sclerosis; SYSTEMIC-SCLEROSIS; NAILFOLD CAPILLAROSCOPY; PREVALENCE; SYMPTOMS;
D O I
10.1007/s10067-015-3062-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Raynaud's phenomenon is a clinical symptom that can commonly present to a primary care provider or generalist. Proper identification of an underlying connective tissue disease in a patient with Raynaud's could allow for the prevention of possible critical digital ischemia. Capillaroscopy is a tool which can identify abnormalities associated with connective tissue disease. Patients presenting with a complaint of Raynaud's phenomenon were assessed with capillaroscopy. In twenty consecutive Raynaud patients, 8 digits were assessed by a x200 magnification dermatoscope and an image was obtained. Each image was assessed for the following abnormalities: drop-out (< 9 capillaries in 1 mm); microhemorrhage; dilated loops; and neoangiogenesis. These 160 images were then shown to 20 primary care physicians, who assessed these same abnormalities. The interrater reliability, a measure of agreement, of individual primary care providers with the expert provider was assessed using kappa statistics. Three raters had slight agreement (in the range 0 to 0.20), one rater had fair agreement (0.21 to 0.40), 11 raters had moderate agreement (0.41 to 0.60), five raters had substantial agreement (0.61 to 0.80), and no rater had almost perfect agreement (0.81 to 1.00) (14). The total agreement from the 20 primary care providers (n = 3,156) was moderate (Ie = 0.50, 95 % CI 0.49, 0.55). For the four providers with the slight to fair interrater reliabilities, the most common disagreement was providing a positive diagnosis when the expert rater diagnosed the digit negative. Ten of the twenty primary care providers provided at least one additional diagnosis following an abnormal diagnosis (n = 35 digits or 35 % of the 1556 abnormal ratings by the primary care providers). The four providers with the poorest interrater reliabilities were not among the ten providers who participated in making these additional specific diagnoses. These providers achieved the moderate agreement with the expert provider for diagnoses of microhemorrhage (Ie = 0.64, 95 % CI 0.57, 0.70), but fair agreement with the expert provider for diagnoses of dilated (Ie = 0.27, 95 % CI 0.20, 0.34) and neoangiogenesis (Ie = 0.22, 95 %CI 0.13, 0.31). Capillaroscopy is a potentially contributive clinical exam skill that could assist primary care providers and generalists in identifying and qualifying changes associated with the common presentation of Raynaud's disease. However, formal training is needed to ensure accuracy and reproducibility. Furthermore, training and scoring systems should address time constraints of busy primary care practitioners.
引用
收藏
页码:2135 / 2140
页数:6
相关论文
共 50 条
  • [1] Primary care assessment of capillaroscopy abnormalities in patients with Raynaud’s phenomenon
    Rebecca Overbury
    Maureen A. Murtaugh
    Aryeh Fischer
    Tracy M. Frech
    Clinical Rheumatology, 2015, 34 : 2135 - 2140
  • [2] Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy
    Bukhari, M
    Hollis, S
    Moore, T
    Jayson, MIV
    Herrick, AL
    RHEUMATOLOGY, 2000, 39 (05) : 506 - 512
  • [3] Comparative evaluation of dermoscopy and capillaroscopy in Raynaud's phenomenon
    Moreau, J.
    Dupond, A. -S.
    Dan, N.
    Untereiner, T.
    Vidal, C.
    Aubin, F.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2017, 144 (05): : 333 - 340
  • [4] Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon
    Meli, M
    Gitzelmann, G
    Koppensteiner, R
    Amann-Vesti, BR
    CLINICAL RHEUMATOLOGY, 2006, 25 (02) : 153 - 158
  • [5] Predictive value of naitfold capillaroscopy in patients with Raynaud’s phenomenon
    Madeleine Meli
    Gabriela Gitzelmann
    Renate Koppensteiner
    Beatrice R. Amann-Vesti
    Clinical Rheumatology, 2006, 25 : 153 - 158
  • [6] Reliability of Widefield Nailfold Capillaroscopy and Videocapillaroscopy in the Assessment of Patients With Raynaud's Phenomenon
    Sekiyama, Juliana Y.
    Camargo, Cintia Z.
    Andrade, Luis Eduardo C.
    Kayser, Cristiane
    ARTHRITIS CARE & RESEARCH, 2013, 65 (11) : 1853 - 1861
  • [7] Assessment of nailfold capillaroscopy by x 30 digital epiluminescence (dermoscopy) in patients with Raynaud phenomenon
    Beltran, E.
    Toll, A.
    Pros, A.
    Carbonell, J.
    Pujol, R. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (05) : 892 - 898
  • [8] The role of capillaroscopy and thermography in the assessment and management of Raynaud's phenomenon
    Herrick, Ariane L.
    Murray, Andrea
    AUTOIMMUNITY REVIEWS, 2018, 17 (05) : 465 - 472
  • [9] Nailfold capillaroscopy in acrocyanosis among patients with associated Raynaud's phenomenon
    Guelimi, R.
    Monfort, J. -B.
    Chaby, G.
    Lok, C.
    Lazareth, I.
    Maillard, H.
    Beneton, N.
    Kottler, D.
    Blaise, S.
    Imbert, B.
    Journet, J.
    Goujon, E.
    Jacquin, A.
    Tella, E.
    Vicaut, E.
    Klejtman, T.
    Senet, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2024, 151 (03):
  • [10] Computerized nailfold video capillaroscopy - A new tool for assessment of Raynaud's phenomenon
    Anderson, ME
    Allen, PD
    Moore, T
    Hillier, V
    Taylor, CJ
    Herrick, AL
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (05) : 841 - 848